Smith Alan E - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Smith Alan E since 12/22/2023

Holdings reported by Smith Alan E for Candel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32.5K $29.3K $0.90 Jul 26, 2021 Direct

There are no transactions reported by Smith Alan E for Candel Therapeutics, Inc.